With extensive experience in venture capital, the fund manager has actively invested across healthcare, technology, and life sciences sectors. Having completed over 30 deals, they emphasize early to growth-stage investments with a strategic, operator-first approach. Notable exits include several high-impact companies in North America and Europe, showcasing a data-driven investment style. Their portfolio reflects a commitment to innovation within dynamic markets, driving substantial returns and fostering sustainable growth.